Literature DB >> 9579164

Duration of growth suppressive effects of regular inhaled corticosteroids.

I J Doull1, M J Campbell, S T Holgate.   

Abstract

The growth of 50 children receiving regular inhaled corticosteroids was segregated into divisions of six weeks from the start of treatment and compared with their growth when not receiving regular corticosteroids using a random effects regression model. Growth suppression was most marked during the initial six weeks after starting treatment, with most suppression occurring during the initial 18 weeks. Thereafter the children's growth was similar to their growth when not receiving treatment. These findings have important consequences for patterns of treatment of asthma in children.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9579164      PMCID: PMC1717466          DOI: 10.1136/adc.78.2.172

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  9 in total

1.  Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids.

Authors:  O D Wolthers; S Pedersen
Journal:  Pediatrics       Date:  1992-05       Impact factor: 7.124

2.  Growth and childhood asthma.

Authors:  L Balfour-Lynn
Journal:  Arch Dis Child       Date:  1986-11       Impact factor: 3.791

3.  Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomised double blind placebo controlled trial.

Authors:  I J Doull; F C Lampe; S Smith; J Schreiber; N J Freezer; S T Holgate
Journal:  BMJ       Date:  1997-10-04

4.  Knemometry, urine cortisol excretion, and measures of the insulin-like growth factor axis and collagen turnover in children treated with inhaled glucocorticosteroids.

Authors:  O D Wolthers; M Hansen; A Juul; H K Nielsen; S Pedersen
Journal:  Pediatr Res       Date:  1997-01       Impact factor: 3.756

5.  Childhood asthma and growth outcome.

Authors:  M Shohat; T Shohat; R Kedem; M Mimouni; Y L Danon
Journal:  Arch Dis Child       Date:  1987-01       Impact factor: 3.791

6.  Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate.

Authors:  I J Doull; N J Freezer; S T Holgate
Journal:  Am J Respir Crit Care Med       Date:  1995-06       Impact factor: 21.405

7.  Growth of asthmatic children during treatment with budesonide: a double blind trial.

Authors:  O D Wolthers; S Pedersen
Journal:  BMJ       Date:  1991-07-20

8.  Growth and the growth hormone axis in prepubertal children with asthma.

Authors:  S Crowley; P C Hindmarsh; D R Matthews; C G Brook
Journal:  J Pediatr       Date:  1995-02       Impact factor: 4.406

9.  Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children.

Authors:  D G Tinkelman; C E Reed; H S Nelson; K P Offord
Journal:  Pediatrics       Date:  1993-07       Impact factor: 7.124

  9 in total
  11 in total

1.  Higher dose inhaled steroids in childhood asthma. Conventional doses do have side effects.

Authors:  H Archer; K Creese; I Doull
Journal:  BMJ       Date:  2001-06-23

2.  The impact of corticosteroids on growth and bone health.

Authors:  T Mushtaq; S F Ahmed
Journal:  Arch Dis Child       Date:  2002-08       Impact factor: 3.791

Review 3.  Inhaled corticosteroids in childhood asthma: long-term effects on growth and adrenocortical function.

Authors:  Alessandro Salvatoni; Elena Piantanida; Luana Nosetti; Luigi Nespoli
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 4.  The effect of asthma and its treatment on growth.

Authors:  I J M Doull
Journal:  Arch Dis Child       Date:  2004-01       Impact factor: 3.791

Review 5.  Inhaled corticosteroids in childhood asthma: growing concerns.

Authors:  K B Witzmann; R J Fink
Journal:  Drugs       Date:  2000       Impact factor: 9.546

Review 6.  Antiasthmatic drug delivery in children.

Authors:  Elizabeth Biggart; Andrew Bush
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 7.  Montelukast: a review of its therapeutic potential in persistent asthma.

Authors:  B Jarvis; A Markham
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

Review 8.  Beclomethasone for asthma in children: effects on linear growth.

Authors:  P J Sharek; D A Bergman
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 9.  Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders.

Authors:  K M Hvizdos; B Jarvis
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546

Review 10.  Treatment of childhood asthma: how do the available options compare?

Authors:  David Coghlan; Colin Powell
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.